TFS Capital’s Synergy Pharmaceuticals SGYP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGYP
BBA
WSA
TFS Capital's SGYP Position: Q2 2014 in Review
TFS Capital sold out of Synergy Pharmaceuticals (SGYP) in Q2 2014, closing a stake of 12,236 shares — an estimated $65K sold.
TFS Capital first reported a position in SGYP in Q2 2013 and held it in 3 quarters. The position peaked at $885K in Q2 2013. 86 funds tracked by Wall St. Rank hold SGYP as of Q2 2014.
- TFS Capital reported no remaining Synergy Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
- TFS Capital sold 12,236 Synergy Pharmaceuticals shares in Q2 2014, an estimated $65K.
- TFS Capital first reported a position in Synergy Pharmaceuticals in Q2 2013 and held it in 3 quarters.
- TFS Capital's Synergy Pharmaceuticals position peaked at $885K in Q2 2013.
- 86 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q2 2014.
Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.